Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02565433 : Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Patient with newly diagnosed brain metastases

- Patient with cancer regardless of the type of primary cancer, with
anatomopathological proof

- At least, one measurable lesion ? 10 mm on the MRI T1 gadolinium sequences

- Number of brain metastases lower or equal to 5

- Indication of radiosurgery treatment

- Age ? 18 years old

- ECOG-PS 0-2

- Expected survival > 3 months

- Ability to complete self-administered questionnaires. If the patient has a motor
disability (hemibody deficit) that does not allow to complete himself the
questionnaires, these will be read by a CRA of the Neurosurgery department who will
outline the questions without making any comment.

- A non-opposition form must have been completed by the patient

Exclusion Criteria:

- Previous cancer (< 5 years) except of carcinoma of cervix uteri, basal cell or
squamous cell skin carcinoma adequately treated

- Previous brain radiotherapy

- Neurological pathology with cognitive disorders existing before the study

- Having a contraindication for MRI

- Associated leptomeningeal disease

- Patients having another severe or uncontrolled pathology which could compromise the
participation at the study (such as infection, cardiovascular, digestive, renal or
pulmonary disease)

- Pregnant or breastfeeding woman. The women must not breastfeed for at least 6 months

- Impossibility to submit to the medical examinations of the study due to geographic,
social or mental reasons
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557